The Academy draws its authority from its Founding Fellowship of clinicians and scientists of repute worldwide, leaders in their fields, who have united to establish the only independent international body representing the interests of the whole spectrum of sciences related to oral oncology.

Fellowship of the Academy is open to all with an interest in the field, subject to certain conditions detailed in the constitution.

Mission

The mission of the Academy is to bring together clinicians and scientists working in the field of oral oncology, so that advances in medical science can be made and translated speedily into benefits for patients.

History

The concept of an international academy to draw together clinicians and scientists working in the field of oral oncology, so that advances in medical science can be made and translated speedily into benefits for patients, arose from the interactions between Alexander Rapidis and Crispian Scully, whilst working together during 2004/2005 as chairmen organising an international congress on oral cancer, in Crete, Greece.

Discussions with their mutual colleague John Langdon, a leading research clinician from UK confirmed that there was a real need for such a formal group. Therefore leading clinicians in the field from USA (Jatin Shah) and Europe (Jean-Louis Lefebvre) were approached to form a steering committee. This committee were requested to nominate a number of active colleagues in the field from around the world, mostly clinicians or scientists recently publishing in the field as identified by MEDLINE. These colleagues were then formally approached personally by telephone. The first 150 contacted were unanimous in their enthusiasm for such an Academy - and thus was established the International Academy of Oral Oncology.

Remit

The International Academy of Oral Oncology [IAOO] encompasses the following aspects of cancers arising in the oral cavity, salivary glands, pharynx, and related craniofacial skeleton, lymph nodes and other tissues

• Natural history of oral cancer and pre-cancer, basic pathology, metastatic mechanisms
• Epidemiology, risk factors, prevention, screening, and intervention
• Cellular and molecular markers for diagnosis and prognosis, oncogenes, viruses, growth factors, adhesion molecules
• Advances in imaging and other functional diagnostic modalities
• Surgical advances, lasers, photodynamic therapy, cryosurgery, micro- vascular and other forms of surgery
• Multimodality treatment, including radiotherapy, chemotherapy, immunotherapy, biological and gene therapy and other novel interventions
• Advances in reconstruction and rehabilitation, including flaps and grafts, alloplasty, bone and connective tissue biology
• Management of complications, including, pain, osteoradionecrosis, xerostomia, psychosocial issues and others
• Oral effects of tumors at both local and distant sites and their treatment
• Teamwork in cancer care, quality of life, restorative dentistry, maxillofacial prosthetics, special care dentistry, nursing, speech and swallowing therapy, nutrition, counseling, as well as palliative and terminal care
• Multicenter studies.

The Academy has a commitment in oral oncology to improve health for present and future generations through

• an interdisciplinary perspective
• objective, impartial interpretation of emerging evidence
• timely application of knowledge and policies
• offering knowledge and education to patients and the public
• education of the cancer team
• excellence in research.

Official Journal

The official Journal of the IAOO is the Journal “Oral Oncology” published by Elsevier Publishers Ltd. Fellows will enjoy free subscription to the Journal.

The Academy has a commitment to

• excellence in research in oral oncology
• objective, impartial interpretation of emerging evidence
• timely application of knowledge and policies to improve health for present and future generations
• an interdisciplinary perspective.

Scope

• Officers
• Founding Fellows
• Council & Committees
• News
• Current Activities
• Events
• Forum
• Publications
• Reports
• Research Support
• Press
• Contact Details

Current Officers and Councilors: 2009-

Officers

President: Jean Louis Lefebvre (France)

President -Elect: Crispian Scully (UK)
Vice-President: Alexis Rapidis (Greece)

Secretary General/: Luiz Kowalski (Brazil)

Treasurer: Patrick J Gullane(Canada)
Executive Director/Company secretary: John Langdon(UK)

Chairman of Council: Jatin P Shah (USA)

Councilors

Jay Boyle, 2013 (USA, New York, Head and Neck Surgery)
Joseph Califano, 2013 (USA, Baltimore, Head and Neck Surgery)
Cyrus Kerawala, 2013 (UK, London, Max. Fax. Surgery)
Ranju Ralhan, 2011 (Canada, Pathology, Epidemiology)
Khee Chee Soo, 2011 (Singapore, Head and Neck Surgery)
Jan Vermorken, 2011(Belgium, Medical Oncology)
William Wei, Hong Kong, China
David Wiesenfeld, 2015 (Australia, Melbourne, Max. Fax. Surgery)

Members at large of the council:
Julia Woolgar (Pathology) UK (2015)
Hans Langendijk (Oncology) The Netherlands (2015)
Yoichiro Kameyama (Pathology) Japan (2015).

The Academy is registered as a non-profit charitable society limited by guarantee in the UK.

Nominating Committee.

Patrick Bradley, UK. (Chair).
Jan Betka, Czech Republic
Ralph Gilbert, Canada
Jan Roodenburg, Belgium
Ashok Shaha, USA.

Last updated: 12/10/2009